Literature DB >> 1633644

Fragile site Xq27.3 in a family without mental retardation.

D R Romain1, C J Chapman.   

Abstract

Routine parental blood analysis for a couple undergoing prenatal diagnosis because of maternal age, revealed a 47,XXX karyotype in the mother and expression of the fragile site Xq27.3 in the father. Additional family studies show the fragile site in the father's sister and her two sons. There is no history of intellectual handicap in this family, nor of any physical manifestations of the Fra(X) mental retardation syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1633644     DOI: 10.1111/j.1399-0004.1992.tb03625.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  Clinical, cytogenetic, and molecular analysis of three families with FRAXE.

Authors:  A J Barnicoat; Q Wang; J Turk; E Green; C G Mathew; G Flynn; V Buckle; M Hirst; K Davies; M Bobrow
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

2.  Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation.

Authors:  G A Flynn; M C Hirst; S J Knight; J N Macpherson; J C Barber; A V Flannery; K E Davies; V J Buckle
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

3.  Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data.

Authors:  B C Hamel; A P Smits; E de Graaff; D F Smeets; F Schoute; B H Eussen; S J Knight; K E Davies; C F Assman-Hulsmans; B A Oostra
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

4.  FRAXF in a patient with chromosome 8 duplication.

Authors:  A M Vianna-Morgante; R C Mingroni-Netto; A C Barbosa; P A Otto; C Rosenberg
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

5.  FRAXE and mental retardation.

Authors:  J C Mulley; S Yu; D Z Loesch; D A Hay; A Donnelly; A K Gedeon; P Carbonell; I López; G Glover; I Gabarrón
Journal:  J Med Genet       Date:  1995-03       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.